Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 13341–13360 of 17,529 recalls

April 7, 2015· Akorn, Inc.

Recalled Item: Hydroxyzine Hydrochloride

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 7, 2015· Akorn, Inc.

Recalled Item: Hydroxyzine Hydrochloride

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 7, 2015· Apotex Inc.

Recalled Item: Olanzapine

The Issue: Subpotent drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 7, 2015· Hospira Inc.

Recalled Item: 0.9% Sodium Chloride Injection

The Issue: Lack of Sterility Assurance: The product has the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 2, 2015· Boehringer Ingelheim Roxane Inc

Recalled Item: Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack

The Issue: Subpotent Drug: The firm received an out of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
March 31, 2015· Cody Laboratories, Inc.

Recalled Item: C-Topical 4% CII (cocaine hydrochloride)

The Issue: Labeling: Label mix-up; bottles were incorrectly labeled as

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 26, 2015· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Fexofenadine Hydrochloride Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 26, 2015· Actavis Laboratories, FL, Inc.

Recalled Item: Cartia XT (diltiazem HCl extended-release capsules

The Issue: Presence of Foreign Substance; fine residue or dust

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 25, 2015· Heritage Pharmaceuticals, Inc.

Recalled Item: GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 25, 2015· Qualitest Pharmaceuticals

Recalled Item: PROMETHAZINE VC WITH CODEINE SYRUP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 24, 2015· Nomax Inc

Recalled Item: Fluorescein Sodium Ophthalmic Strips USP

The Issue: Failed Content Uniformity Specifications: The product may not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 24, 2015· Nomax Inc

Recalled Item: Fluorescein Sodium Ophthalmic Strips USP

The Issue: Failed Content Uniformity Specifications: The product may not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 24, 2015· Baxter Healthcare Corp.

Recalled Item: 0.9% Sodium Chloride Injection

The Issue: Presence of Particulate Matter: Products recalled due to

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 24, 2015· Baxter Healthcare Corp.

Recalled Item: Lactated Ringers Injection

The Issue: Presence of Particulate Matter: Products recalled due to

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 24, 2015· Baxter Healthcare Corp.

Recalled Item: 10% Dextrose Injection

The Issue: Presence of Particulate Matter: Products recalled due to

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 24, 2015· Baxter Healthcare Corp.

Recalled Item: 5% Dextrose Injection

The Issue: Presence of Particulate Matter: Products recalled due to

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 24, 2015· Nomax Inc

Recalled Item: Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP

The Issue: Failed Content Uniformity Specifications: The product may not

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 23, 2015· Mylan Institutional LLC

Recalled Item: Gemcitabine for Injection

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 23, 2015· Mylan Institutional LLC

Recalled Item: Gemcitabine for Injection

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 23, 2015· Mylan Institutional LLC

Recalled Item: Gemcitabine for Injection

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund